Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
Cancers|September 10, 2021
Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future DirectionsJonathan Thouvenin, Nieves Martínez Chanzá, Omar Alhalabi, et al.The Oncologist|June 14, 2023
Racial Disparities in MiT Family Translocation Renal Cell CarcinomaXiaofan Lu, Nassim Tawanaie Pour Sedehi, Xiaoping Su, et al.Blood|October 24, 2014
Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factorEvi X Stavrou, Chao Fang, Alona Merkulova, et al.Journal of Cancer Research and Clinical Oncology|December 31, 2022
Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitisAlice Saji, Maneera Chopra, Jake Jacob, et al.Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Systematic Review and Meta-Analysis of Cisplatin Based Neoadjuvant Chemotherapy in Muscle Invasive Bladder CancerRaed Benkhadra, Tarek Nayfeh, Sai Krishna Patibandla, et al.Frontiers in Oncology|January 19, 2024
Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patientsIuliia Kovalenko, Wern Lynn Ng, Yimin Geng, et al.Frontiers in Medicine|May 21, 2016
A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular DiseaseHaley R Gittleman, Alona Merkulova, Omar Alhalabi, et al.Journal of Cancer Research and Clinical Oncology|August 28, 2022
Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effectsCynthia Liu, Rajan Amin, Malek Shatila, et al.Current Oncology (Toronto, Ont.)|June 26, 2024
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed StrategyMohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.Journal of Cancer Research and Clinical Oncology|September 27, 2022
Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patientsAntony Mathew, Malek Shatila, Zongshan Lai, et al.Pageof 8